drugset / Trial / NCT01468636
A RTC to Examine the Effectiveness of 400 mg of Oral Zinc Gluconate as Adjunctive Therapy for Ano-genital Warts
Phase 4
Terminated
50 enrolled
University of British Columbia
British Columbia Centre for Disease Control · collab
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to examine the effect of 400 mg of oral zinc gluconate on genital warts. Our hypothesis is that there will be a 10% difference in complete clearance of genital warts in the group randomized to oral plus standard of care compared to those randomized to placebo plus standard of care.
Timeline
- Start
- 2011-11
- Primary completion
- 2012-01
- Completion
- 2012-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Zinc gluconate | Small molecule | 200 mg | Oral |